Iradimed (IRMD) Total Current Liabilities (2013 - 2026)

Iradimed (IRMD) has 14 years of Total Current Liabilities data on file, last reported at $12.1 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $12.1 million, up 43.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 43.01% YoY), and the FY2025 annual result was $10.2 million, up 19.6% from the prior year.
• Total Current Liabilities rose to $12.1 million in Q1 2026 per IRMD's latest filing, from $10.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $16.3 million in Q4 2023 and troughed at $5.6 million in Q3 2022.
• A 5-year average of $8.8 million and a median of $8.1 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 90.88% in 2023, then slumped 47.87% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $8.6 million in 2022, then soared by 90.88% to $16.3 million in 2023, then slumped by 47.87% to $8.5 million in 2024, then grew by 19.6% to $10.2 million in 2025, then grew by 19.04% to $12.1 million in 2026.
• Business Quant data shows IRMD's Total Current Liabilities at $12.1 million in Q1 2026, $10.2 million in Q4 2025, and $12.8 million in Q3 2025.